MEN2A, also known as Sipple syndrome, has an estimated prevalence of 1 in 36,000 to 1 in 200,000 live births (Table 1) [90], and is characterized by MTC, PHEO and PHPT. The gene discussed is RET; the disease is multiple endocrine neoplasia type 2A.